Iceland vs Paraguay: Cause of death, by non-communicable diseases, ages 5-14
Iceland
41.7%
in 2021
Paraguay
41.2%
in 2021
Iceland rank
75th
Paraguay rank
78th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Iceland
- Paraguay
How they compare
Iceland currently reports 41.7% against 41.2% in Paraguay, a difference of 0.5%.
The two have swapped places 4 times across 6 shared years of data; in 2000 it was Iceland ahead.
Iceland ranks 75th and Paraguay ranks 78th of 185 countries.
Across the 3 decades both report, Iceland averaged higher in 2 and Paraguay in 1.
Head to head by decade
| Decade | Iceland | Paraguay | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 52.9% | 38.5% | 14.4% | Iceland |
| 2010s | 66.1% | 48.2% | 17.9% | Iceland |
| 2020s | 41.1% | 43.9% | 2.8% | Paraguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Iceland or Paraguay?
- Iceland, at 41.7% against 41.2% in Paraguay as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Iceland and Paraguay?
- 0.5%, with Iceland ahead.
- How many years of comparable data are there for Iceland and Paraguay?
- 6 years are reported by both, from 2000 to 2021.
- How do Iceland and Paraguay rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Iceland ranks 75th and Paraguay ranks 78th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.